Connecta Therapeutics raises €1.7 M to develop new treatment for fragile X syndrome

by Parc Científic de Barcelona

Connecta Therapeutics has closed a €1.7 million round of investment led by Inveready that will allow the company to take its first drug through to phase IIa clinical trials in patients who have frag...

Read more

Connecta Therapeutics raises €1.7 M in a round led by Inveready to develop new treatment for fragile X syndrome

by Inveready

Connecta Therapeutics has closed a €1.7 million round of investment led by Inveready that will allow the company to take its first drug through to phase IIa clinical trials in patients who have frag...

Read more

SOM Biotech is awarded a grant from CDTI to start clinical trials with a drug inhibitor of SARS- COV-2 replication

by Som Biotech

SOM B​iotechhas been granted €340,000.00 from the Center for Industrial Te​chnological Development (CDTI, Spain), within the extraordinary call for grants for R&D projects to face the COVID-19 h...

Read more

The biotech company, Oxolife, raises 5 million euros for its Phase II Clinical Trial

by Oxolife

The biotech company Oxolife, created to develop a new treatment to improve the female fertility rate, completed its first funding round by raising 5,000,000 euros in an investment led by Inveready Ass...

Read more

Palobiofarma joins the fight against the Covid-19 pandemia

by Palobiofarma

The company announced the initiation a of a drug discovery program towards the identification of novel oral drugs specifically designed to treat infections caused by Corona viruses.

Read more

Alta Life Sciences and CDTI invest €7.6M in Accure Therapeutics, a new company that will develop a portfolio of new medicines to address CNS diseases

by Alta Life Sciences / CDTI

Accure Therapeutics, a new pharma R&D player in the Central Nervous System (CNS) field, announces today its launch with a Series A round of funding totalling €7.6 million ($8.1M). The funding round ...

Read more

La Caixa launches a venture capital fund for driving the creation and growth of start-ups in the scientific field

by Caixa Capital Risc

Caixa Innvierte Start is the eighth venture capital fund driven by the ”la Caixa” venture capital firm. With this new vehicle, Caixa Capital Risc now manages an investment volume of 180 million Eu...

Read more

Laboratorios Ordesa leads the Smart Foods project

by Parc Científic de Barcelona

El objetivo de esta investigación será el diseño de alimentos y test de screening, que permitan reducir el riesgo de algunas de las enfermedades crónicas más frecuentes, que serán causantes de 3...

Read more

Minoryx raises 1.6M€ in a round led by Caixa Capital Risc

by Expansión

La Caixa is leading this operation through the Caixa Innvierte BioMed II fund, joined by the Sanfilippo Foundation Switzerland

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

El Plan Integral de eliminación de Hepa...

by Hospital Universitario Virgen de la Macarena

​Esta estrategia ha proporcionado facilidades de derivación desde a...

Photos Stream